Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (11-20 of 536) with videos related to

Pageof 54
Sort By:
Current Opinion in Hematology|January 31, 2015
Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemiaCelalettin Ustun, Guido Marcucci
Expert Review of Hematology|November 14, 2012
Molecular prognostic factors in cytogenetically normal acute myeloid leukemiaAlison Walker, Guido Marcucci
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markersAlison R Walker, Guido Marcucci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implicationsGuido Marcucci, Torsten Haferlach, Hartmut Döhner
Oncology (Williston Park, N.Y.)|April 18, 2016
Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic InsightsSamer Khaled, Monzr Al Malki, Guido Marcucci
Oncology (Williston Park, N.Y.)|December 18, 2016
Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in ChildrenIbrahim T Aldoss, Guido Marcucci, Vinod Pullarkat
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003Guido Marcucci, Danilo Perrotti, Michael A Caligiuri
Nature Reviews. Drug Discovery|October 2, 2010
Targeting microRNAs in cancer: rationale, strategies and challengesRamiro Garzon, Guido Marcucci, Carlo M Croce
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradoxDanilo Perrotti, Guido Marcucci, Michael A Caligiuri
Current Opinion in Hematology|December 18, 2004
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsGuido Marcucci, Krzysztof Mrózek, Clara D Bloomfield
Pageof 54

Showing results (11-20 of 536) with videos related to

Sort By:
Pageof 54
Current Opinion in Hematology|January 31, 2015
Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemiaCelalettin Ustun, Guido Marcucci
Expert Review of Hematology|November 14, 2012
Molecular prognostic factors in cytogenetically normal acute myeloid leukemiaAlison Walker, Guido Marcucci
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2014
Management of patients with cytogenetically normal acute myeloid leukemia who have neither favorable nor unfavorable markersAlison R Walker, Guido Marcucci
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implicationsGuido Marcucci, Torsten Haferlach, Hartmut Döhner
Oncology (Williston Park, N.Y.)|April 18, 2016
Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic InsightsSamer Khaled, Monzr Al Malki, Guido Marcucci
Oncology (Williston Park, N.Y.)|December 18, 2016
Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in ChildrenIbrahim T Aldoss, Guido Marcucci, Vinod Pullarkat
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Understanding the molecular basis of imatinib mesylate therapy in chronic myelogenous leukemia and the related mechanisms of resistance. Commentary re: A. N. Mohamed et al., The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations. Clin. Cancer Res., 9: 1333-1337, 2003Guido Marcucci, Danilo Perrotti, Michael A Caligiuri
Nature Reviews. Drug Discovery|October 2, 2010
Targeting microRNAs in cancer: rationale, strategies and challengesRamiro Garzon, Guido Marcucci, Carlo M Croce
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradoxDanilo Perrotti, Guido Marcucci, Michael A Caligiuri
Current Opinion in Hematology|December 18, 2004
Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsGuido Marcucci, Krzysztof Mrózek, Clara D Bloomfield
Pageof 54